The Senate Resolution introduced by Pennycuick and others on June 6, 2025, urges the United States Congress to expand treatment options for veterans and service members suffering from post-traumatic stress disorder (PTSD) by authorizing stellate ganglion block (SGB) therapy through the passage of H.R. 1947, known as the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act. The resolution highlights the effectiveness of SGB, a low-risk procedure that has been used since the 1920s, in alleviating common PTSD symptoms such as hyperarousal and anxiety. It notes that a significant percentage of veterans from various conflicts, including Operation Enduring Freedom and the Vietnam War, are diagnosed with PTSD, yet only 40% find relief with current treatments.

The resolution emphasizes the urgent need for effective PTSD treatments, as untreated symptoms are linked to a higher risk of suicide among veterans, with an alarming statistic of 20 veteran suicides occurring daily in the United States. By supporting H.R. 1947, the resolution aims to direct the Secretaries of Veterans Affairs and Defense to provide SGB therapy to those in need. The resolution has garnered support from various organizations, including the Pennsylvania National Guard Associations and the American Legion, and calls for copies to be sent to key government officials to advocate for this important legislative change.